Abstract
FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF PERAMPANEL IMMEDIATE RELEASE TABLETS | Open Access
Volume 2024 - 1 | Article ID 217 | http://dx.doi.org/10.62057/ESJ.2024.V1.I3
FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF PERAMPANEL IMMEDIATE RELEASE TABLETS
Received 2024-02-29 |
Revised 2024-03-04 |
Accepted 2024-03-05 |
Published 2024-03-10 |
The aim of the present study is to develop and evaluate the immediate
release tablet of Perampanel by direct compression method. The
superdisintegrant crospovidone (CP), croscarmellose sodium (CCS) and sodium
starch glycolate (SSG) were used for immediate release of drug from tablet. The
prepared tablets were evaluated for all pre-compression parameters and
post-compression parameters. The drug excipients interaction was investigated
by FTIR. All formulation showed compliances with Pharmacopoeial standards. The
study reveals that formulations prepared by direct compression F3 exhibit
highest dissolution using crospovidone showed faster drug release 99.13 % over
the period of 45min.